Cargando…

HbA1c variability predicts cardiovascular complications in type 2 diabetes regardless of being at glycemic target

BACKGROUND: HbA1c variability has emerged as risk factor for cardiovascular diseases in diabetes. However, the impact of HbA1c variability on cardiovascular diseases in subjects within the recommended HbA1c target has been relatively unexplored. METHODS: Using data from a large database, we studied...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ceriello, Antonio, Lucisano, Giuseppe, Prattichizzo, Francesco, La Grotta, Rosalba, Franzén, Stefan, Svensson, Ann-Marie, Eliasson, Björn, Nicolucci, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788128/ https://www.ncbi.nlm.nih.gov/pubmed/35073913 http://dx.doi.org/10.1186/s12933-022-01445-4

Ejemplares similares

Variability in body weight and the risk of cardiovascular complications in type 2 diabetes: results from the Swedish National Diabetes Register
por: Ceriello, Antonio, et al.
Publicado: (2021)

Empagliflozin reduced long-term HbA1c variability and cardiovascular death: insights from the EMPA-REG OUTCOME trial
por: Ceriello, Antonio, et al.
Publicado: (2020)

Incremental role of glycaemic variability over HbA1c in identifying type 2 diabetic patients with high platelet reactivity undergoing percutaneous coronary intervention
por: Nusca, Annunziata, et al.
Publicado: (2019)

The True Value of HbA1c as a Predictor of Diabetic Complications: Simulations of HbA1c Variables
por: Lind, Marcus, et al.
Publicado: (2009)

Visit-to-visit HbA1c variability is inversely related to baroreflex sensitivity independently of HbA1c value in type 2 diabetes
por: Matsutani, Daisuke, et al.
Publicado: (2018)

Variability of risk factors and diabetes complications
por: Ceriello, Antonio, et al.
Publicado: (2021)

HbA1c variability and diabetic peripheral neuropathy in type 2 diabetic patients
por: Su, Jian-bin, et al.
Publicado: (2018)

The legacy effect of hyperglycemia and early use of SGLT-2 inhibitors: a cohort study with newly-diagnosed people with type 2 diabetes
por: Ceriello, Antonio, et al.
Publicado: (2023)

Glucose-sensing microRNA-21 disrupts ROS homeostasis and impairs antioxidant responses in cellular glucose variability
por: La Sala, Lucia, et al.
Publicado: (2018)

Effect of Hyperglycemia on COVID-19 Outcomes: Vaccination Efficacy, Disease Severity, and Molecular Mechanisms
por: Sardu, Celestino, et al.
Publicado: (2022)

Influence of Serum Albumin on HbA1c and HbA1c-Defined Glycemic Status: A Retrospective Study
por: Feng, Xiaojing, et al.
Publicado: (2021)

Glycemic Variability: Both Sides of the Story
por: Ceriello, Antonio, et al.
Publicado: (2013)

Fasting plasma glucose variability and HbA1c are associated with peripheral artery disease risk in type 2 diabetes
por: Yang, Chun-Pai, et al.
Publicado: (2020)

Socioeconomic Factors Associated With Glycemic Measurement and Poor HbA1c Control in People With Type 2 Diabetes: The Global DISCOVER Study
por: Gomes, Marília B., et al.
Publicado: (2022)

Relative contributions of preprandial and postprandial glucose exposures, glycemic variability, and non-glycemic factors to HbA(1c) in individuals with and without diabetes
por: Færch, Kristine, et al.
Publicado: (2018)

Repurposing SGLT-2 Inhibitors to Target Aging: Available Evidence and Molecular Mechanisms
por: La Grotta, Rosalba, et al.
Publicado: (2022)

Prognostic impact of HbA1c variability on long-term outcomes in patients with heart failure and type 2 diabetes mellitus
por: Gu, Jun, et al.
Publicado: (2018)

Comparative predictive ability of visit-to-visit HbA1c variability measures for microvascular disease risk in type 2 diabetes
por: Yang, Chen-Yi, et al.
Publicado: (2020)

The relationship between HbA(1c) and ultrasound plaque textures in atherosclerotic patients
por: Huang, Xiao-Wei, et al.
Publicado: (2016)

Plasma metabolites mediate the effect of HbA1c on incident cardiovascular disease
por: Dong, Xuesi, et al.
Publicado: (2019)

Relative contributions of fasting and postprandial glucose increments, glycemic variability, and non‐glycemic factors to HbA1c in individuals with type 1 diabetes
por: Zhou, Yongwen, et al.
Publicado: (2023)

Visit-to-visit HbA(1c) variability is associated with in-stent restenosis in patients with type 2 diabetes after percutaneous coronary intervention
por: Yang, Chen Die, et al.
Publicado: (2020)

An Evaluation of Point-of-Care HbA1c, HbA1c Home Kits, and Glucose Management Indicator: Potential Solutions for Telehealth Glycemic Assessments
por: Zaharieva, Dessi P., et al.
Publicado: (2022)

The relationship between glycemic variability and diabetic peripheral neuropathy in type 2 diabetes with well-controlled HbA1c
por: Xu, Feng, et al.
Publicado: (2014)

HbA1c variability and long-term glycemic control are linked to peripheral neuropathy in patients with type 1 diabetes
por: Pinto, M. V., et al.
Publicado: (2020)

Association of HbA1c With All-cause Mortality Across Varying Degrees of Glycemic Variability in Type 2 Diabetes
por: Lu, Jingyi, et al.
Publicado: (2021)

Postprandial Hyperglycemia and Glycemic Variability: Should we care?
por: Standl, Eberhard, et al.
Publicado: (2011)

Optimal glucose, HbA1c, glucose-HbA1c ratio and stress-hyperglycaemia ratio cut-off values for predicting 1-year mortality in diabetic and non-diabetic acute myocardial infarction patients
por: Sia, Ching-Hui, et al.
Publicado: (2021)

Glycemic Profiles of Healthy Individuals with Low Fasting Plasma Glucose and HbA1c
por: Nomura, Kyoko, et al.
Publicado: (2011)

Relationship between HbA1c, fructosamine and clinical assessment of glycemic control in dogs
por: Norris, Olga, et al.
Publicado: (2022)

On the Association between Implant-Supported Prosthesis and Glycemic Control (HbA1c Values)
por: Masri, Daya, et al.
Publicado: (2022)

ODP237 Relation Between Long Term Glycemic Variability (LTGV) and HbA1c Time-In-Range in Diabetic Patients.
por: Delgado-Vazquez, Angel Jesus, et al.
Publicado: (2022)

Erratum. Overall Quality of Care Predicts the Variability of Key Risk Factors for Complications in Type 2 Diabetes: An Observational, Longitudinal Retrospective Study. Diabetes Care 2019;42:514–519
por: Ceriello, Antonio, et al.
Publicado: (2020)

HbA(1c) Variability as an Independent Correlate of Nephropathy, but Not Retinopathy, in Patients With Type 2 Diabetes: The Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study
por: Penno, Giuseppe, et al.
Publicado: (2013)

Cardiorenal and other diabetes related outcomes with SGLT-2 inhibitors compared to GLP-1 receptor agonists in type 2 diabetes: nationwide observational study
por: Lugner, Moa, et al.
Publicado: (2021)

Glycated Albumin Versus HbA1c in the Evaluation of Glycemic Control in Patients With Diabetes and CKD
por: Gan, Ting, et al.
Publicado: (2017)

Assessment of Glycemic Control in Patients With Diabetes in Northern Sudan Using Calculated HbA1c
por: Abdel bagi, Omer, et al.
Publicado: (2022)

Measurement of HbA(1c) and HbA(2) by Capillarys 2 Flex Piercing HbA(1c) programme for simultaneous management of diabetes and screening for thalassemia
por: Ke, Peifeng, et al.
Publicado: (2017)

Rapid-Acting Insulin Analogues Versus Regular Human Insulin: A Meta-Analysis of Effects on Glycemic Control in Patients with Diabetes
por: Nicolucci, Antonio, et al.
Publicado: (2019)

Trajectories in HbA1c and other risk factors among adults with type 1 diabetes by age at onset
por: Edqvist, Jon, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0n80705jph96bq118ng80qnidp